PRESS RELEASE: Tessella and Berry Consultants partner to produce a tool that allows trial designer to evaluate, compare and optimize adaptive designs
Companies announce availability of fixed and adaptive clinical trial simulator – Tessella Berry FACTS™
College Station, Texas| Oxford, UK – April 29, 2009. Today, Tessella, the information technology and consulting services company selected by R&D, science and engineering leaders for business-critical assignments, partners with Berry Consultants, leaders in the Bayesian approach to medical statistics. Under the terms of the agreement Tessella and Berry Consultants will make available a jointly developed fixed and adaptive clinical trials simulator: Tessella Berry FACTS™.
Tessella Berry FACTS supports key steps in the design of an adaptive trial.
· Quick assessment of the likely benefit of using an adaptive design for a trial;
· Comparison of the many design options including the choice of response model, longitudinal model and adaptation strategy;
· Refinement of trial design to optimize operating characteristics;
· Creation of a simulation report;
“Berry Consultants are world leaders in the design and implementation of adaptive clinical trials with more than 40 trials to their credit,” said Tom Parke, Head of Clinical Technologies at Tessella. “We are delighted to work with Berry Consultants and to harness their knowhow in a robust, productized offering that will both reduce the barrier to adoption of adaptive clinical trials and ensure that the technique is used most effectively,” he added.
“Tessella has a great track record in the successful delivery of informatics solutions to pharmaceutical and bio-tech companies,” said Prof. Don Berry. “I am delighted to be working with them and believe that the availability of Tessella Berry FACTS marks an important step in the development of the adaptive approach to clinical trials.”
About Berry consultants
Berry Consultants is a statistical consulting group specializing in adaptive clinical trial design in pharmaceutical and medical device research and development. We are leaders in the Bayesian approach to medical statistics. This approach is radically changing the way research is done throughout the medical industry (device and drug development). We employ world renown experts in Bayesian statistics and strive to set the standard for Bayesian design and analysis in the statistical and medical communities.
About Tessella
For decades, Tessella has been successfully delivering IT and consulting services to world leaders in R&D, science and engineering. We enable our clients in life sciences, energy, the public sector, and consumer industries to achieve a wide range of objectives, including, forecasting floods, developing fusion power, enhancing military sensor capability, improving drug discovery and development efficiency, and reducing risk to health and the environment in the extraction and production of oil and gas. With offices in Europe and North America, global companies rely on Tessella for business critical assignments.
Further information is available at www.tessella.com
-Ends-
Tessella
Christina Tealdi | Marketing Communications & PR Executive
Phone: +44 (0) 1235 555511 | Mobile: + 44 (0) 779 9346453


